knowledge -WSS

knowledge

author：leisure time 2025-10-01 11:36:31 - browse：1242

There’s a specter haunting Wall Street.

It started in biotech, where companies making drugs for the obesity-related liver disease NASH saw their valuations crash on the assumption that GLP-1 weight loss treatments would cut them out of the market. Then the Ozempic panic came for dialysis firms, whose stocks fell about 20% in a single day on the news that Novo Nordisk’s medicine had delayed the progression of kidney disease in a study enrolling people with type 2 diabetes.

Now analysts from every sector are cranking out research notes on the disparate, dramatic, and often debatable implications of GLP-1 drugs’ growing popularity, said Jared Holz, a health care specialist at Mizuho Securities. Buy Bumble, sell McDonald’s. Short Pepsi, go long Louis Vuitton. Put your money in sectors that cater to a svelte and sated brand of consumer, and get out of the ones that rely on excess and compulsion.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： AbbVie dramatically boosts its spending on lobbying

WSS

HIPAA doesn't protect reproductive records from prosecutors

CDC backtracks, saying fully vaccinated people can go maskless indoors

Russian special forces kill a gunman who broke into a private house near Moscow

Organ transplantation is at a crossroads. Major reform is needed

Virginia high school admissions case could be legal follow

Guidelines to prevent youth baseball injuries need more muscle

entertainment

knowledge

hotspot

Hepatitis C has a cure — but many Americans still lack access to it

As Taiwan prepares for anti

Medicare proposal to cover medical devices draws a mixed reaction

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

FDA approval of Sarepta Duchenne genetic therapy gives me hope

CDC backtracks, saying fully vaccinated people can go maskless indoors

Medicare details structure of new drug price negotiation program

Southern California school board OKs curriculum after Gov. Gavin Newsom threatened a $1.5M fine

Medical leaders decry Supreme Court decision on affirmative action

Organ transplantation is at a crossroads. Major reform is needed

Wikipedia

Medicare proposal to cover medical devices draws a mixed reaction

Death toll from an explosion and collapse of a Paris building in June climbs to 3

Contact tracing may help avoid another lockdown. Can it work in the U.S.?

Virginia high school admissions case could be legal follow

The high cost of giving birth even with insurance

Affirmative action in medical school literally saved lives

Wikipedia

entertainment

entertainment

hotspot